<!DOCTYPE html>
<!-- saved from url=(0040)https://peptidestandard.com/store/pt141/ -->
<html class="js no-touch" lang="en"><!--<![endif]--><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8">

  <title>PT-141 - Peptide Standard</title>

  <meta property="og:title" content="PT-141"><meta property="og:url" content="https://peptidestandard.com/store/pt141/"><meta property="og:type" content="article"><meta property="og:site_name" content="Peptide Standard"><meta name="description" content="





FULL CHEMICAL NAME
PT-141, known as Bremelanotide, is a synthetic cyclic heptapeptide with the full chemical name N-acetyl-L-norleucyl-L-aspartyl-L-histidyl-D-phenylalanyl-L-arginyl-L-tryptophyl-L-lysine lactam. Structurally, it comprises seven amino acids (Ac-Nle-Asp-His-D-Phe-Arg-Trp-Lys) arranged in a macrocyclic ring, formed by a lactam bridge between the aspartic acid (Asp) and lysine (Lys) side chains, with an acetyl group capping the N-terminus. Its molecular weight is approximately 1025.2 Da, reflecting a compact yet potent configuration designed to mimic and enhance melanocortin receptor agonism, distinguishing it from its linear predecessor, Melanotan II.
&amp;amp;nbsp;ALIASES
PT-141 is most prominently known as Bremelanotide, its clinical designation. It&amp;amp;rsquo;s occasionally referenced as a melanocortin analog or MC4R agonist in research contexts, owing to its affinity for melanocortin-4 receptors. Historically linked to Melanotan II (MT-II), from which it was derived via structural optimization, it&amp;amp;rsquo;s differentiated by its cyclic nature and specific therapeutic focus. In biochemical literature, it may appear as Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2, emphasizing its lactam ring&amp;amp;mdash;a shorthand for its intricate design.
&amp;amp;nbsp;EMERGING TRENDS IN RESEARCH
Emerging research on PT-141 highlights its potential beyond its established role in sexual dysfunction, probing broader neuroendocrine and behavioral applications. Hypotheses suggest its melanocortin receptor agonism (primarily MC4R) could modulate appetite suppression and energy homeostasis, drawing parallels with natural melanocyte-stimulating hormone (MSH). Neuroscientific studies explore its influence on reward pathways, with rodent data hinting at anxiolytic effects and enhanced social bonding via hypothalamic and amygdala activation (Pfaus et al., 2004; Molinoff et al., 2003). Its anti-inflammatory potential emerges in preclinical models, possibly via MC1R/MC4R-mediated cytokine modulation, suggesting utility in neuroinflammatory conditions. Interest also grows in its cardiovascular effects, with speculation about blood pressure regulation through central melanocortin pathways&amp;amp;mdash;though human data remains limited outside sexual health, urging further translational exploration (Kingsberg et al., 2019).
&amp;amp;nbsp;LESS TECHNICAL EXPLANATION
Researchers are studying PT-141 for more than just sexual health. They think it might help control appetite, improve mood, reduce inflammation, or even affect blood pressure&amp;amp;mdash;interesting possibilities still being tested.
&amp;amp;nbsp;NOTABLE INTERACTIONS
PT-141 interacts intricately with the melanocortin system, exhibiting high affinity for MC4R and moderate binding to MC1R and MC3R, triggering cAMP production via G-protein-coupled receptor signaling (Molinoff et al., 2003). It synergizes with endogenous &amp;amp;alpha;-MSH, amplifying hypothalamic responses, and may potentiate dopamine release in the medial preoptic area (mPOA), enhancing sexual arousal (Pfaus et al., 2004). In vitro, it shows no significant interaction with serotonin or opioid receptors, but its MC4R agonism could indirectly modulate leptin signaling in energy balance studies. Its bioavailability surpasses Melanotan II due to cyclization, resisting enzymatic cleavage by peptidases&amp;amp;mdash;a pharmacokinetic edge (Kingsberg et al., 2019).
&amp;amp;nbsp;LESS TECHNICAL EXPLANATION
PT-141 works with the melanocortin system, mainly the MC4R receptor, to send signals that can increase cell activity. It teams up with a natural hormone (&amp;amp;alpha;-MSH) in the brain and may boost dopamine for arousal. It doesn&amp;amp;rsquo;t mix with serotonin or opioids but could subtly affect hunger signals. Its ring shape helps it last longer in the body.
&amp;amp;nbsp;PREPARATION INSTRUCTIONS
In rats, PT-141 (0.1&amp;amp;ndash;1 mg/kg, subcutaneous) increases sexual solicitations by 2- to 3-fold within 30 minutes, with erection frequency rising 50&amp;amp;ndash;70% (Molinoff et al., 2003). Human trials (10 mg, subcutaneous) in women with hypoactive sexual desire disorder (HSDD) report a 40&amp;amp;ndash;50% increase in satisfying sexual events (SSEs) over 4 weeks vs. placebo (Kingsberg et al., 2019). In obese mice, 0.5 mg/kg reduces food intake by 20&amp;amp;ndash;25% over 24 hours, hinting at metabolic effects (Pfaus et al., 2004). These metrics showcase PT-141&amp;amp;rsquo;s potency in sexual and appetitive domains&amp;amp;mdash;quantitative proof of its receptor-driven efficacy.
&amp;amp;nbsp;LESS TECHNICAL EXPLANATION
In rats, PT-141 (0.1&amp;amp;ndash;1 mg/kg) doubles or triples sexual interest and boosts erections by 50&amp;amp;ndash;70% in 30 minutes. In women, 10 mg increases satisfying sexual moments by 40&amp;amp;ndash;50% in a month. In heavy mice, 0.5 mg/kg cuts eating by 20&amp;amp;ndash;25% in a day&amp;amp;mdash;clear signs it works on behavior and appetite.
&amp;amp;nbsp;CONTRAINDICATIONS OR WARNINGS FOR RESEARCH USE
PT-141 carries standard research warnings: &amp;amp;lsquo;Not for human consumption outside approved trials,&amp;amp;rsquo; &amp;amp;lsquo;For laboratory use only,&amp;amp;rsquo; and requires IRB/IACUC adherence. As an FDA-approved drug (Vyleesi) for HSDD, its research use pivots to non-therapeutic models&amp;amp;mdash;off-label exploration demands ethical oversight. No unique contraindications emerge beyond its clinical profile; however, transient hypertension noted in humans (Kingsberg et al., 2019) suggests monitoring cardiovascular parameters in high-dose studies.
&amp;amp;nbsp;LESS TECHNICAL EXPLANATION
PT-141 has lab rules: &amp;amp;lsquo;Not for eating unless in approved tests&amp;amp;rsquo; and &amp;amp;lsquo;Research only.&amp;amp;rsquo; It&amp;amp;rsquo;s a real drug for sexual issues, so extra studies need careful permission. It&amp;amp;rsquo;s generally fine, but watch blood pressure in big doses since that&amp;amp;rsquo;s been seen in people.
&amp;amp;nbsp;PREPARATION INSTRUCTIONS
Reconstitute PT-141 in sterile bacteriostatic water at 1 mg/mL under aseptic conditions&amp;amp;mdash;its cyclic structure enhances stability (half-life ~2&amp;amp;ndash;3 hours in vivo). Store lyophilized powder at -20&amp;amp;deg;C, desiccated and light-protected; post-reconstitution, keep at 2&amp;amp;ndash;8&amp;amp;deg;C and use within 2&amp;amp;ndash;4 weeks to maintain potency. Avoid freeze-thaw cycles to preserve the lactam ring&amp;amp;mdash;optimal pH is 5.5&amp;amp;ndash;6.5 to minimize hydrolysis (Molinoff et al., 2003).
&amp;amp;nbsp;LESS TECHNICAL EXPLANATION
Mix PT-141 in sterile water with a preservative (1 mg/mL) and keep it clean. Store the dry form at -20&amp;amp;deg;C away from light and moisture. After mixing, refrigerate and use within 2&amp;amp;ndash;4 weeks. Don&amp;amp;rsquo;t freeze and thaw it&amp;amp;mdash;keep it steady for best results.
&amp;amp;nbsp;CLINICAL TRIALS AND HUMAN RESEARCH
Bremelanotide (PT-141) is FDA-approved as Vyleesi for HSDD in premenopausal women, with Phase III trials (10 mg, subcutaneous) showing 40&amp;amp;ndash;50% SSE improvement vs. placebo (Kingsberg et al., 2019). Earlier trials (e.g., NCT01382719) tested 1.25&amp;amp;ndash;1.75 mg in men and women, boosting arousal scores by 30&amp;amp;ndash;40% (Diamond et al., 2006). Preclinical rodent studies dominate broader applications (Pfaus et al., 2004)&amp;amp;mdash;human data focuses narrowly on sexual dysfunction.
&amp;amp;nbsp;LESS TECHNICAL EXPLANATION
PT-141, or Bremelanotide, is an approved drug (Vyleesi) for women with low sexual desire, improving satisfaction by 40&amp;amp;ndash;50% in studies. It&amp;amp;rsquo;s also been tested for arousal in men and women, raising it 30&amp;amp;ndash;40%. Animal research looks at other uses, but human tests stick to sexual health so far.
&amp;amp;nbsp;EFFECTS ON DIFFERENT TISSUE TYPES
PT-141 targets brain tissues, activating hypothalamic MC4R to enhance sexual behavior (Pfaus et al., 2004). In adipose tissue, it curbs appetite via MC4R in obese models (Molinoff et al., 2003). Vascular effects include transient blood pressure elevation (5&amp;amp;ndash;10 mmHg) via central melanocortin signaling&amp;amp;mdash;tissue-specific responses dominate its profile (Kingsberg et al., 2019).
&amp;amp;nbsp;LESS TECHNICAL EXPLANATION
PT-141 affects the brain to increase sexual interest, reduces hunger in fat tissue, and slightly raises blood pressure through brain signals&amp;amp;mdash;its effects depend on the tissue.
&amp;amp;nbsp;EFFICACY IN ANIMAL MODELS
In rats, PT-141 (0.1&amp;amp;ndash;1 mg/kg) doubles sexual solicitations and boosts penile erections by 50&amp;amp;ndash;70% (Molinoff et al., 2003). In obese mice, 0.5 mg/kg cuts food intake by 20&amp;amp;ndash;25% (Pfaus et al., 2004). Human data mirrors rodent sexual efficacy&amp;amp;mdash;clinical consistency across species.
&amp;amp;nbsp;LESS TECHNICAL EXPLANATION
In rats, PT-141 (0.1&amp;amp;ndash;1 mg/kg) doubles mating interest and increases erections by 50&amp;amp;ndash;70%. In overweight mice, 0.5 mg/kg reduces eating by 20&amp;amp;ndash;25%. People show similar sexual boosts&amp;amp;mdash;animals and humans align well.
&amp;amp;nbsp;FUTURE RESEARCH
Future PT-141 research could explore appetite regulation, anxiety reduction, or inflammation control via MC4R/MC1R agonism, leveraging its neuroendocrine reach (Pfaus et al., 2004). Synergy with dopamine modulators or anti-inflammatory agents might broaden its scope&amp;amp;mdash;human trials beyond HSDD beckon.
&amp;amp;nbsp;LESS TECHNICAL EXPLANATION
Future studies might test PT-141 for hunger control, easing worry, or calming inflammation, using its brain effects. Combining it with other compounds could open new doors&amp;amp;mdash;more human research is the next step.
&amp;amp;nbsp;HISTORY OF MODELS TESTED
PT-141 has been tested in rats (Pfaus et al., 2004), mice (Molinoff et al., 2003), and human trials (Kingsberg et al., 2019; Diamond et al., 2006)&amp;amp;mdash;no in vitro cell culture data is prominent.
&amp;amp;nbsp;LESS TECHNICAL EXPLANATION
PT-141 has been studied in rats, mice, and people&amp;amp;mdash;no major lab dish tests are noted.
&amp;amp;nbsp;TOXICITY DATA AVAILABLE
No LD50 data exists for PT-141&amp;amp;mdash;rat doses up to 10 mg/kg show no acute toxicity (Molinoff et al., 2003). Human trials at 10 mg report transient nausea (25%) and hypertension (5&amp;amp;ndash;10 mmHg), but no severe effects (Kingsberg et al., 2019).
&amp;amp;nbsp;LESS TECHNICAL EXPLANATION
There&amp;amp;rsquo;s no danger limit for PT-141&amp;amp;mdash;rats handle 10 mg/kg fine, and people at 10 mg might feel sick or have higher blood pressure briefly, but nothing serious shows up.
&amp;amp;nbsp;MECHANISM OF ACTION
PT-141 acts as a potent MC4R agonist, elevating cAMP via GPCR signaling in hypothalamic neurons, amplifying &amp;amp;alpha;-MSH effects on sexual arousal and appetite suppression (Molinoff et al., 2003). It may enhance dopamine release in the mPOA, with MC1R/MC3R contributing minor anti-inflammatory or vascular roles (Pfaus et al., 2004).
&amp;amp;nbsp;LESS TECHNICAL EXPLANATION
PT-141 activates MC4R receptors in the brain, increasing cell signals that boost sexual interest and reduce hunger. It may also raise dopamine slightly and have small effects on inflammation or blood vessels.
&amp;amp;nbsp;METABOLIC AND PHYSIOLOGICAL EFFECTS
PT-141 enhances sexual behavior (50&amp;amp;ndash;70% erection increase in rats) and reduces food intake (20&amp;amp;ndash;25% in mice), with transient blood pressure elevation (5&amp;amp;ndash;10 mmHg) in humans (Kingsberg et al., 2019; Pfaus et al., 2004).
&amp;amp;nbsp;LESS TECHNICAL EXPLANATION
PT-141 increases sexual activity by 50&amp;amp;ndash;70% in rats and cuts eating by 20&amp;amp;ndash;25% in mice. In people, it slightly raises blood pressure for a short time.
&amp;amp;nbsp;SAFETY AND SIDE EFFECTS
In humans, PT-141 (10 mg) causes nausea (25%), headache (10%), and transient hypertension (5&amp;amp;ndash;10 mmHg) lasting 2&amp;amp;ndash;4 hours (Kingsberg et al., 2019). Rats show no adverse effects at 1 mg/kg (Molinoff et al., 2003)&amp;amp;mdash;mild clinical profile.
&amp;amp;nbsp;LESS TECHNICAL EXPLANATION
In people, PT-141 (10 mg) may lead to nausea (25%), headaches (10%), or a brief blood pressure rise. Rats at 1 mg/kg show no issues&amp;amp;mdash;side effects are mild.
&amp;amp;nbsp;ADMINISTRATION METHODS RECOMMENDED
Subcutaneous injection at 0.1&amp;amp;ndash;1 mg/kg in rodents (Pfaus et al., 2004) or 10 mg in humans (Kingsberg et al., 2019); reconstitute in bacteriostatic water (1 mg/mL), store at 2&amp;amp;ndash;8&amp;amp;deg;C, use within 2&amp;amp;ndash;4 weeks.
&amp;amp;nbsp;LESS TECHNICAL EXPLANATION
Inject PT-141 under the skin&amp;amp;mdash;0.1&amp;amp;ndash;1 mg/kg for rodents or 10 mg for people. Mix in preservative water (1 mg/mL), keep refrigerated, and use within 2&amp;amp;ndash;4 weeks.
&amp;amp;nbsp;ADVERSE EFFECTS REPORTED
Nausea (25%), headache (10%), and hypertension (5&amp;amp;ndash;10 mmHg) in humans at 10 mg (Kingsberg et al., 2019); no significant effects in rats at 1 mg/kg (Molinoff et al., 2003).
&amp;amp;nbsp;LESS TECHNICAL EXPLANATION
In people, 10 mg PT-141 might cause nausea (25%), headaches (10%), or a short blood pressure bump&amp;amp;mdash;no big problems in rats at 1 mg/kg.
&amp;amp;nbsp;KEY OBSERVATIONS FROM PEER REVIEWED STUDIES
PT-141 boosts SSEs by 40&amp;amp;ndash;50% in women with HSDD (Kingsberg et al., 2019); enhances rat erections by 50&amp;amp;ndash;70% (Molinoff et al., 2003); reduces mouse food intake by 20&amp;amp;ndash;25% (Pfaus et al., 2004)&amp;amp;mdash;robust findings.
&amp;amp;nbsp;LESS TECHNICAL EXPLANATION
PT-141 raises satisfying sexual events by 40&amp;amp;ndash;50% in women, increases rat erections by 50&amp;amp;ndash;70%, and lowers mouse eating by 20&amp;amp;ndash;25%&amp;amp;mdash;strong study results.
&amp;amp;nbsp;LIMITATIONS OF CURRENT RESEARCH DATA
Human data is HSDD-centric; broader effects (appetite, mood) lack large-scale trials; long-term safety is uncharted (Kingsberg et al., 2019).
&amp;amp;nbsp;LESS TECHNICAL EXPLANATION
Most human research is on sexual desire&amp;amp;mdash;appetite or mood effects need bigger studies, and long-term safety isn&amp;amp;rsquo;t clear yet.
&amp;amp;nbsp;RESEARCH BASED OBSERVATIONS
PT-141 enhances sexual function, suppresses appetite, and may reduce anxiety or inflammation&amp;amp;mdash;primarily brain-driven effects (Pfaus et al., 2004).
&amp;amp;nbsp;LESS TECHNICAL EXPLANATION
PT-141 improves sexual behavior, reduces hunger, and might ease stress or inflammation&amp;amp;mdash;mainly through the brain.
&amp;amp;nbsp;SPECIFIC EFFECTS OBSERVED IN VITRO OR VIVO
In rats, 50&amp;amp;ndash;70% erection increase (Molinoff et al., 2003); in humans, 40&amp;amp;ndash;50% SSE boost (Kingsberg et al., 2019); in mice, 20&amp;amp;ndash;25% less food intake (Pfaus et al., 2004).
&amp;amp;nbsp;LESS TECHNICAL EXPLANATION
In rats, erections rise 50&amp;amp;ndash;70%; in people, sexual satisfaction increases 40&amp;amp;ndash;50%; in mice, eating drops 20&amp;amp;ndash;25%.
&amp;amp;nbsp;TYPICAL DOSES USED IN RESEARCH
0.1&amp;amp;ndash;1 mg/kg in rodents (Pfaus et al., 2004); 10 mg in humans (Kingsberg et al., 2019).
&amp;amp;nbsp;LESS TECHNICAL EXPLANATION
Rodents get 0.1&amp;amp;ndash;1 mg/kg; people use 10 mg in studies.
&amp;amp;nbsp;UNANSWERED QUESTIONS NEEDING INVESTIGATION
Long-term effects, non-sexual applications, and optimal dosing remain unresolved (Kingsberg et al., 2019).
&amp;amp;nbsp;LESS TECHNICAL EXPLANATION
What happens long-term, other uses, and best doses are still unknown.
&amp;amp;nbsp;BIOCHEMICAL PATHWAYS OR RECEPTORS TARGETED BY PEPTIDE
MC4R agonism elevates cAMP, enhancing &amp;amp;alpha;-MSH signaling; minor MC1R/MC3R effects possible (Molinoff et al., 2003).
&amp;amp;nbsp;LESS TECHNICAL EXPLANATION
PT-141 boosts MC4R signals, mimicking a hormone to affect behavior and possibly inflammation.
&amp;amp;nbsp;POTENTIAL RESEARCH EXPLORATIONS
Synergy with dopamine agonists, anti-inflammatory roles, or anxiety studies via MC4R (Pfaus et al., 2004).
&amp;amp;nbsp;

"><link rel="canonical" href="https://peptidestandard.com/store/pt141/"><meta name="platform" content="bigcommerce.stencil"><meta property="og:description" content="





FULL CHEMICAL NAME
PT-141, known as Bremelanotide, is a synthetic cyclic heptapeptide with the full chemical name N-acetyl-L-norleucyl-L-aspartyl-L-histidyl-D-phenylalanyl-L-arginyl-L-tryptophyl-L-lysine lactam. Structurally, it comprises seven amino acids (Ac-Nle-Asp-His-D-Phe-Arg-Trp-Lys) arranged in a macrocyclic ring, formed by a lactam bridge between the aspartic acid (Asp) and lysine (Lys) side chains, with an acetyl group capping the N-terminus. Its molecular weight is approximately 1025.2 Da, reflecting a compact yet potent configuration designed to mimic and enhance melanocortin receptor agonism, distinguishing it from its linear predecessor, Melanotan II.
&amp;nbsp;ALIASES
PT-141 is most prominently known as Bremelanotide, its clinical designation. It&amp;rsquo;s occasionally referenced as a melanocortin analog or MC4R agonist in research contexts, owing to its affinity for melanocortin-4 receptors. Historically linked to Melanotan II (MT-II), from which it was derived via structural optimization, it&amp;rsquo;s differentiated by its cyclic nature and specific therapeutic focus. In biochemical literature, it may appear as Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2, emphasizing its lactam ring&amp;mdash;a shorthand for its intricate design.
&amp;nbsp;EMERGING TRENDS IN RESEARCH
Emerging research on PT-141 highlights its potential beyond its established role in sexual dysfunction, probing broader neuroendocrine and behavioral applications. Hypotheses suggest its melanocortin receptor agonism (primarily MC4R) could modulate appetite suppression and energy homeostasis, drawing parallels with natural melanocyte-stimulating hormone (MSH). Neuroscientific studies explore its influence on reward pathways, with rodent data hinting at anxiolytic effects and enhanced social bonding via hypothalamic and amygdala activation (Pfaus et al., 2004; Molinoff et al., 2003). Its anti-inflammatory potential emerges in preclinical models, possibly via MC1R/MC4R-mediated cytokine modulation, suggesting utility in neuroinflammatory conditions. Interest also grows in its cardiovascular effects, with speculation about blood pressure regulation through central melanocortin pathways&amp;mdash;though human data remains limited outside sexual health, urging further translational exploration (Kingsberg et al., 2019).
&amp;nbsp;LESS TECHNICAL EXPLANATION
Researchers are studying PT-141 for more than just sexual health. They think it might help control appetite, improve mood, reduce inflammation, or even affect blood pressure&amp;mdash;interesting possibilities still being tested.
&amp;nbsp;NOTABLE INTERACTIONS
PT-141 interacts intricately with the melanocortin system, exhibiting high affinity for MC4R and moderate binding to MC1R and MC3R, triggering cAMP production via G-protein-coupled receptor signaling (Molinoff et al., 2003). It synergizes with endogenous &amp;alpha;-MSH, amplifying hypothalamic responses, and may potentiate dopamine release in the medial preoptic area (mPOA), enhancing sexual arousal (Pfaus et al., 2004). In vitro, it shows no significant interaction with serotonin or opioid receptors, but its MC4R agonism could indirectly modulate leptin signaling in energy balance studies. Its bioavailability surpasses Melanotan II due to cyclization, resisting enzymatic cleavage by peptidases&amp;mdash;a pharmacokinetic edge (Kingsberg et al., 2019).
&amp;nbsp;LESS TECHNICAL EXPLANATION
PT-141 works with the melanocortin system, mainly the MC4R receptor, to send signals that can increase cell activity. It teams up with a natural hormone (&amp;alpha;-MSH) in the brain and may boost dopamine for arousal. It doesn&amp;rsquo;t mix with serotonin or opioids but could subtly affect hunger signals. Its ring shape helps it last longer in the body.
&amp;nbsp;PREPARATION INSTRUCTIONS
In rats, PT-141 (0.1&amp;ndash;1 mg/kg, subcutaneous) increases sexual solicitations by 2- to 3-fold within 30 minutes, with erection frequency rising 50&amp;ndash;70% (Molinoff et al., 2003). Human trials (10 mg, subcutaneous) in women with hypoactive sexual desire disorder (HSDD) report a 40&amp;ndash;50% increase in satisfying sexual events (SSEs) over 4 weeks vs. placebo (Kingsberg et al., 2019). In obese mice, 0.5 mg/kg reduces food intake by 20&amp;ndash;25% over 24 hours, hinting at metabolic effects (Pfaus et al., 2004). These metrics showcase PT-141&amp;rsquo;s potency in sexual and appetitive domains&amp;mdash;quantitative proof of its receptor-driven efficacy.
&amp;nbsp;LESS TECHNICAL EXPLANATION
In rats, PT-141 (0.1&amp;ndash;1 mg/kg) doubles or triples sexual interest and boosts erections by 50&amp;ndash;70% in 30 minutes. In women, 10 mg increases satisfying sexual moments by 40&amp;ndash;50% in a month. In heavy mice, 0.5 mg/kg cuts eating by 20&amp;ndash;25% in a day&amp;mdash;clear signs it works on behavior and appetite.
&amp;nbsp;CONTRAINDICATIONS OR WARNINGS FOR RESEARCH USE
PT-141 carries standard research warnings: &amp;lsquo;Not for human consumption outside approved trials,&amp;rsquo; &amp;lsquo;For laboratory use only,&amp;rsquo; and requires IRB/IACUC adherence. As an FDA-approved drug (Vyleesi) for HSDD, its research use pivots to non-therapeutic models&amp;mdash;off-label exploration demands ethical oversight. No unique contraindications emerge beyond its clinical profile; however, transient hypertension noted in humans (Kingsberg et al., 2019) suggests monitoring cardiovascular parameters in high-dose studies.
&amp;nbsp;LESS TECHNICAL EXPLANATION
PT-141 has lab rules: &amp;lsquo;Not for eating unless in approved tests&amp;rsquo; and &amp;lsquo;Research only.&amp;rsquo; It&amp;rsquo;s a real drug for sexual issues, so extra studies need careful permission. It&amp;rsquo;s generally fine, but watch blood pressure in big doses since that&amp;rsquo;s been seen in people.
&amp;nbsp;PREPARATION INSTRUCTIONS
Reconstitute PT-141 in sterile bacteriostatic water at 1 mg/mL under aseptic conditions&amp;mdash;its cyclic structure enhances stability (half-life ~2&amp;ndash;3 hours in vivo). Store lyophilized powder at -20&amp;deg;C, desiccated and light-protected; post-reconstitution, keep at 2&amp;ndash;8&amp;deg;C and use within 2&amp;ndash;4 weeks to maintain potency. Avoid freeze-thaw cycles to preserve the lactam ring&amp;mdash;optimal pH is 5.5&amp;ndash;6.5 to minimize hydrolysis (Molinoff et al., 2003).
&amp;nbsp;LESS TECHNICAL EXPLANATION
Mix PT-141 in sterile water with a preservative (1 mg/mL) and keep it clean. Store the dry form at -20&amp;deg;C away from light and moisture. After mixing, refrigerate and use within 2&amp;ndash;4 weeks. Don&amp;rsquo;t freeze and thaw it&amp;mdash;keep it steady for best results.
&amp;nbsp;CLINICAL TRIALS AND HUMAN RESEARCH
Bremelanotide (PT-141) is FDA-approved as Vyleesi for HSDD in premenopausal women, with Phase III trials (10 mg, subcutaneous) showing 40&amp;ndash;50% SSE improvement vs. placebo (Kingsberg et al., 2019). Earlier trials (e.g., NCT01382719) tested 1.25&amp;ndash;1.75 mg in men and women, boosting arousal scores by 30&amp;ndash;40% (Diamond et al., 2006). Preclinical rodent studies dominate broader applications (Pfaus et al., 2004)&amp;mdash;human data focuses narrowly on sexual dysfunction.
&amp;nbsp;LESS TECHNICAL EXPLANATION
PT-141, or Bremelanotide, is an approved drug (Vyleesi) for women with low sexual desire, improving satisfaction by 40&amp;ndash;50% in studies. It&amp;rsquo;s also been tested for arousal in men and women, raising it 30&amp;ndash;40%. Animal research looks at other uses, but human tests stick to sexual health so far.
&amp;nbsp;EFFECTS ON DIFFERENT TISSUE TYPES
PT-141 targets brain tissues, activating hypothalamic MC4R to enhance sexual behavior (Pfaus et al., 2004). In adipose tissue, it curbs appetite via MC4R in obese models (Molinoff et al., 2003). Vascular effects include transient blood pressure elevation (5&amp;ndash;10 mmHg) via central melanocortin signaling&amp;mdash;tissue-specific responses dominate its profile (Kingsberg et al., 2019).
&amp;nbsp;LESS TECHNICAL EXPLANATION
PT-141 affects the brain to increase sexual interest, reduces hunger in fat tissue, and slightly raises blood pressure through brain signals&amp;mdash;its effects depend on the tissue.
&amp;nbsp;EFFICACY IN ANIMAL MODELS
In rats, PT-141 (0.1&amp;ndash;1 mg/kg) doubles sexual solicitations and boosts penile erections by 50&amp;ndash;70% (Molinoff et al., 2003). In obese mice, 0.5 mg/kg cuts food intake by 20&amp;ndash;25% (Pfaus et al., 2004). Human data mirrors rodent sexual efficacy&amp;mdash;clinical consistency across species.
&amp;nbsp;LESS TECHNICAL EXPLANATION
In rats, PT-141 (0.1&amp;ndash;1 mg/kg) doubles mating interest and increases erections by 50&amp;ndash;70%. In overweight mice, 0.5 mg/kg reduces eating by 20&amp;ndash;25%. People show similar sexual boosts&amp;mdash;animals and humans align well.
&amp;nbsp;FUTURE RESEARCH
Future PT-141 research could explore appetite regulation, anxiety reduction, or inflammation control via MC4R/MC1R agonism, leveraging its neuroendocrine reach (Pfaus et al., 2004). Synergy with dopamine modulators or anti-inflammatory agents might broaden its scope&amp;mdash;human trials beyond HSDD beckon.
&amp;nbsp;LESS TECHNICAL EXPLANATION
Future studies might test PT-141 for hunger control, easing worry, or calming inflammation, using its brain effects. Combining it with other compounds could open new doors&amp;mdash;more human research is the next step.
&amp;nbsp;HISTORY OF MODELS TESTED
PT-141 has been tested in rats (Pfaus et al., 2004), mice (Molinoff et al., 2003), and human trials (Kingsberg et al., 2019; Diamond et al., 2006)&amp;mdash;no in vitro cell culture data is prominent.
&amp;nbsp;LESS TECHNICAL EXPLANATION
PT-141 has been studied in rats, mice, and people&amp;mdash;no major lab dish tests are noted.
&amp;nbsp;TOXICITY DATA AVAILABLE
No LD50 data exists for PT-141&amp;mdash;rat doses up to 10 mg/kg show no acute toxicity (Molinoff et al., 2003). Human trials at 10 mg report transient nausea (25%) and hypertension (5&amp;ndash;10 mmHg), but no severe effects (Kingsberg et al., 2019).
&amp;nbsp;LESS TECHNICAL EXPLANATION
There&amp;rsquo;s no danger limit for PT-141&amp;mdash;rats handle 10 mg/kg fine, and people at 10 mg might feel sick or have higher blood pressure briefly, but nothing serious shows up.
&amp;nbsp;MECHANISM OF ACTION
PT-141 acts as a potent MC4R agonist, elevating cAMP via GPCR signaling in hypothalamic neurons, amplifying &amp;alpha;-MSH effects on sexual arousal and appetite suppression (Molinoff et al., 2003). It may enhance dopamine release in the mPOA, with MC1R/MC3R contributing minor anti-inflammatory or vascular roles (Pfaus et al., 2004).
&amp;nbsp;LESS TECHNICAL EXPLANATION
PT-141 activates MC4R receptors in the brain, increasing cell signals that boost sexual interest and reduce hunger. It may also raise dopamine slightly and have small effects on inflammation or blood vessels.
&amp;nbsp;METABOLIC AND PHYSIOLOGICAL EFFECTS
PT-141 enhances sexual behavior (50&amp;ndash;70% erection increase in rats) and reduces food intake (20&amp;ndash;25% in mice), with transient blood pressure elevation (5&amp;ndash;10 mmHg) in humans (Kingsberg et al., 2019; Pfaus et al., 2004).
&amp;nbsp;LESS TECHNICAL EXPLANATION
PT-141 increases sexual activity by 50&amp;ndash;70% in rats and cuts eating by 20&amp;ndash;25% in mice. In people, it slightly raises blood pressure for a short time.
&amp;nbsp;SAFETY AND SIDE EFFECTS
In humans, PT-141 (10 mg) causes nausea (25%), headache (10%), and transient hypertension (5&amp;ndash;10 mmHg) lasting 2&amp;ndash;4 hours (Kingsberg et al., 2019). Rats show no adverse effects at 1 mg/kg (Molinoff et al., 2003)&amp;mdash;mild clinical profile.
&amp;nbsp;LESS TECHNICAL EXPLANATION
In people, PT-141 (10 mg) may lead to nausea (25%), headaches (10%), or a brief blood pressure rise. Rats at 1 mg/kg show no issues&amp;mdash;side effects are mild.
&amp;nbsp;ADMINISTRATION METHODS RECOMMENDED
Subcutaneous injection at 0.1&amp;ndash;1 mg/kg in rodents (Pfaus et al., 2004) or 10 mg in humans (Kingsberg et al., 2019); reconstitute in bacteriostatic water (1 mg/mL), store at 2&amp;ndash;8&amp;deg;C, use within 2&amp;ndash;4 weeks.
&amp;nbsp;LESS TECHNICAL EXPLANATION
Inject PT-141 under the skin&amp;mdash;0.1&amp;ndash;1 mg/kg for rodents or 10 mg for people. Mix in preservative water (1 mg/mL), keep refrigerated, and use within 2&amp;ndash;4 weeks.
&amp;nbsp;ADVERSE EFFECTS REPORTED
Nausea (25%), headache (10%), and hypertension (5&amp;ndash;10 mmHg) in humans at 10 mg (Kingsberg et al., 2019); no significant effects in rats at 1 mg/kg (Molinoff et al., 2003).
&amp;nbsp;LESS TECHNICAL EXPLANATION
In people, 10 mg PT-141 might cause nausea (25%), headaches (10%), or a short blood pressure bump&amp;mdash;no big problems in rats at 1 mg/kg.
&amp;nbsp;KEY OBSERVATIONS FROM PEER REVIEWED STUDIES
PT-141 boosts SSEs by 40&amp;ndash;50% in women with HSDD (Kingsberg et al., 2019); enhances rat erections by 50&amp;ndash;70% (Molinoff et al., 2003); reduces mouse food intake by 20&amp;ndash;25% (Pfaus et al., 2004)&amp;mdash;robust findings.
&amp;nbsp;LESS TECHNICAL EXPLANATION
PT-141 raises satisfying sexual events by 40&amp;ndash;50% in women, increases rat erections by 50&amp;ndash;70%, and lowers mouse eating by 20&amp;ndash;25%&amp;mdash;strong study results.
&amp;nbsp;LIMITATIONS OF CURRENT RESEARCH DATA
Human data is HSDD-centric; broader effects (appetite, mood) lack large-scale trials; long-term safety is uncharted (Kingsberg et al., 2019).
&amp;nbsp;LESS TECHNICAL EXPLANATION
Most human research is on sexual desire&amp;mdash;appetite or mood effects need bigger studies, and long-term safety isn&amp;rsquo;t clear yet.
&amp;nbsp;RESEARCH BASED OBSERVATIONS
PT-141 enhances sexual function, suppresses appetite, and may reduce anxiety or inflammation&amp;mdash;primarily brain-driven effects (Pfaus et al., 2004).
&amp;nbsp;LESS TECHNICAL EXPLANATION
PT-141 improves sexual behavior, reduces hunger, and might ease stress or inflammation&amp;mdash;mainly through the brain.
&amp;nbsp;SPECIFIC EFFECTS OBSERVED IN VITRO OR VIVO
In rats, 50&amp;ndash;70% erection increase (Molinoff et al., 2003); in humans, 40&amp;ndash;50% SSE boost (Kingsberg et al., 2019); in mice, 20&amp;ndash;25% less food intake (Pfaus et al., 2004).
&amp;nbsp;LESS TECHNICAL EXPLANATION
In rats, erections rise 50&amp;ndash;70%; in people, sexual satisfaction increases 40&amp;ndash;50%; in mice, eating drops 20&amp;ndash;25%.
&amp;nbsp;TYPICAL DOSES USED IN RESEARCH
0.1&amp;ndash;1 mg/kg in rodents (Pfaus et al., 2004); 10 mg in humans (Kingsberg et al., 2019).
&amp;nbsp;LESS TECHNICAL EXPLANATION
Rodents get 0.1&amp;ndash;1 mg/kg; people use 10 mg in studies.
&amp;nbsp;UNANSWERED QUESTIONS NEEDING INVESTIGATION
Long-term effects, non-sexual applications, and optimal dosing remain unresolved (Kingsberg et al., 2019).
&amp;nbsp;LESS TECHNICAL EXPLANATION
What happens long-term, other uses, and best doses are still unknown.
&amp;nbsp;BIOCHEMICAL PATHWAYS OR RECEPTORS TARGETED BY PEPTIDE
MC4R agonism elevates cAMP, enhancing &amp;alpha;-MSH signaling; minor MC1R/MC3R effects possible (Molinoff et al., 2003).
&amp;nbsp;LESS TECHNICAL EXPLANATION
PT-141 boosts MC4R signals, mimicking a hormone to affect behavior and possibly inflammation.
&amp;nbsp;POTENTIAL RESEARCH EXPLORATIONS
Synergy with dopamine agonists, anti-inflammatory roles, or anxiety studies via MC4R (Pfaus et al., 2004).
&amp;nbsp;

">
<meta property="og:image" content="https://peptidestandard.com/product_images/uploaded_images/pt-141-gradient.jpg">

  

  <link href="https://cdn11.bigcommerce.com/s-q1sponaupn/product_images/favicon_1.png?t=1739995112" rel="shortcut icon">
  <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">
  <meta http-equiv="X-UA-Compatible" content="ie=edge">

  <script nonce="">
    function browserSupportsAllFeatures() {
        return window.Promise
            && window.fetch
            && window.URL
            && window.URLSearchParams
            && window.WeakMap
            // object-fit support
            && ('objectFit' in document.documentElement.style);
    }

    function loadScript(src) {
        var js = document.createElement('script');
        js.src = src;
        js.nonce = "";
        js.onerror = function () {
            console.error('Failed to load polyfill script ' + src);
        };
        document.head.appendChild(js);
    }

    if (!browserSupportsAllFeatures()) {
        loadScript('https://cdn11.bigcommerce.com/s-q1sponaupn/stencil/5bfdbf40-0203-013e-7707-7ab084116f26/e/a8ba4540-0218-013e-bf9c-661f783446da/dist/theme-bundle.polyfills.js');
    }
</script>

  <script nonce="">
    window.lazySizesConfig = window.lazySizesConfig || {};
    window.lazySizesConfig.loadMode = 1;
  </script>
  <script nonce="" async="" src="./PT-141 - Peptide Standard_files/theme-bundle.head_async.js"></script>

  <link data-stencil-stylesheet="" href="./PT-141 - Peptide Standard_files/theme-e42e28a0-2926-013e-5cfa-3a9b5fd13228.css" rel="stylesheet">
  <link href="./PT-141 - Peptide Standard_files/css" rel="stylesheet">

  
<script type="text/javascript">
var BCData = {};
</script>
<script>
window.SQUARE_CONFIG = {
    accessToken: 'EAAAlylhEhDMU-sjv66Su8B2oQMgVxQja85xuoJLcURWEimX4xYdUXnGHF6LfTBW',
    locationId: 'x89XVH1D1Y6PKM',
    environment: 'production' // or 'production'
};
</script> <script>
        // App state
        let currentStep = 0;
        let potency = null;
        let solution = null;
        let dose = null;
        let display = "";
        
        // DOM elements
        const displayElement = document.getElementById('display');
        const guidanceElement = document.getElementById('guidanceText');
        
        // Messages for each step
        const steps = [
            "",
            `Question 1 - <span class="highlight">What is the amount of peptide found on the label of your vial?<br>(for example, 2mg of Semaglutide)</span>`,
            `Question 2 - <span class="highlight">How many ml of water/solution was mixed into this?<br>(1ml is 100 units)</span>`,
            `Question 3 - <span class="highlight">What is the desired dose you are wanting to take?<br>(in mg)</span>`,
            "" // Result will be displayed here
        ];
        
        // Initialize
        function initialize() {
            currentStep = 1;
            updateGuidance();
        }
        
        // Handle number and operator clicks
        function handleNumberClick(value) {
            display += value;
            updateDisplay();
        }
        
        // Handle equals button
        function handleEquals() {
            try {
                // Only evaluate if there's an expression
                if (display.includes('+') || display.includes('-') || display.includes('*') || display.includes('/')) {
                    const result = eval(display);
                    display = result.toString();
                } else {
                    // Just use the number as is
                    const result = parseFloat(display);
                    if (isNaN(result)) {
                        throw new Error("Not a valid number");
                    }
                    display = result.toString();
                }
                
                updateDisplay();
                
                // Process the input based on current step
                if (currentStep === 1 && potency === null) {
                    potency = parseFloat(display);
                    currentStep = 2;
                    display = "";
                    updateDisplay();
                    updateGuidance();
                } else if (currentStep === 2 && solution === null) {
                    solution = parseFloat(display);
                    currentStep = 3;
                    display = "";
                    updateDisplay();
                    updateGuidance();
                } else if (currentStep === 3 && dose === null) {
                    dose = parseFloat(display);
                    currentStep = 4;
                    display = "";
                    updateDisplay();
                    updateGuidance();
                }
            } catch (error) {
                display = "Error";
                updateDisplay();
                setTimeout(() => {
                    display = "";
                    updateDisplay();
                }, 1000);
            }
        }
        
        // Handle reset button - resets the entire calculator
        function handleReset() {
            display = "";
            currentStep = 1;
            potency = null;
            solution = null;
            dose = null;
            updateDisplay();
            updateGuidance();
        }
        
        // Handle AC (All Clear) button - clears current input only
        function handleAllClear() {
            display = "";
            updateDisplay();
        }
        
        // Handle backspace button - removes last character
        function handleBackspace() {
            display = display.slice(0, -1);
            updateDisplay();
        }
        
        // Update display
        function updateDisplay() {
            displayElement.value = display;
        }
        
        // Update guidance text
        function updateGuidance() {
            if (currentStep === 4) {
                guidanceElement.innerHTML = calculateDosage();
            } else {
                guidanceElement.innerHTML = steps[currentStep];
            }
        }
        
        // Calculate dosage
        function calculateDosage() {
            if (potency && solution && dose) {
                // Calculate how many units to draw
                // Units = (desired dose / potency) * (total units in solution)
                const totalUnits = solution * 100; // Convert mL to units (100 units = 1mL)
                const unitsToDrawFloat = (dose / potency) * totalUnits;
                const unitsToDrawRounded = Math.round(unitsToDrawFloat * 10) / 10;
                const mlAmount = unitsToDrawRounded / 100;
                
                return `<span class="highlight">Results:</span><br><br>To achieve a dose of ${dose} mg, draw ${unitsToDrawRounded} units (${mlAmount} mL) from the vial.<br><br>Press the reset button (↻) to start over.`;
            }
            return 'Error calculating dosage. Please try again.';
        }
        
        // Initialize the app when the page loads
        window.onload = initialize;
    </script>
 <script data-cfasync="false" src="./PT-141 - Peptide Standard_files/index.js" integrity="sha256-Y0tDj1qsyiKBRibKllwV0ZJ1aFlGYaHHGl/oUFoXJ7Y=" nonce="" crossorigin="anonymous"></script>
 <script data-cfasync="false" nonce="">

 (function() {
    function decodeBase64(base64) {
       const text = atob(base64);
       const length = text.length;
       const bytes = new Uint8Array(length);
       for (let i = 0; i < length; i++) {
          bytes[i] = text.charCodeAt(i);
       }
       const decoder = new TextDecoder();
       return decoder.decode(bytes);
    }
    window.bodl = JSON.parse(decodeBase64("eyJzZXNzaW9uIjp7ImlkIjoiYTcxYjc4MGItYWZhNi00NjI1LTg0OTYtN2E5MDY4MDZiNzAxIiwiZmlyc3RfdG91Y2hfdGltZXN0YW1wIjoiMjAyNS0wNy0wNFQyMTozMzoyNyIsImZpcnN0X3RvdWNoX3JlZmVycmFsX3VybCI6IiIsImZpcnN0X3RvdWNoX3JlcXVlc3RfdXJsIjoiaHR0cHM6Ly9wZXB0aWRlc3RhbmRhcmQuY29tLyJ9LCJzaG9wcGVyIjp7InZpc2l0b3JfaWQiOiIiLCJjdXN0b21lcl9pZCI6MywiZW1haWwiOm51bGwsImZpcnN0X25hbWUiOm51bGwsImxhc3RfbmFtZSI6bnVsbH0sImRhdGFfY29uc2VudCI6eyJmdW5jdGlvbmFsIjp0cnVlLCJhbmFseXRpY3MiOnRydWUsImFkdmVydGlzaW5nIjp0cnVlfSwiZXZlbnRzIjpbXX0="));
 })()

 </script>

  

  































































  <!-- snippet location html_head -->

  
<script nonce="" type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "WebSite",
    "name": "Peptide Standard",
    "url": "https://peptidestandard.com/"
  }
</script>
</head>

<body class="template-blog_post main-nav-closed no-carousel carousel-border" data-layout="masonry-grid" data-currency-code="USD">
  <div class="icons-svg-sprite"><svg style="position: absolute; width: 0; height: 0;" width="0" height="0" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
  <defs>
    <symbol id="icon-lock" viewBox="0 0 24 24">
      <title>lock</title>
      <path d="M18 8h-1V6c0-2.76-2.24-5-5-5S7 3.24 7 6v2H6c-1.1 0-2 .9-2 2v10c0 1.1.9 2 2 2h12c1.1 0 2-.9 2-2V10c0-1.1-.9-2-2-2zm-6 9c-1.1 0-2-.9-2-2s.9-2 2-2 2 .9 2 2-.9 2-2 2zm3.1-9H8.9V6c0-1.71 1.39-3.1 3.1-3.1 1.71 0 3.1 1.39 3.1 3.1v2z"></path>
    </symbol>

    <symbol id="icon-plus" viewBox="0 0 10 10">
      <title>plus</title>
      <path d="M4.5 4.5H0v1h4.5V10h1V5.5H10v-1H5.5V0h-1v4.5z"></path>
    </symbol>

    <symbol id="icon-star" viewBox="0 0 15 14">
      <path d="M7.083 11.374l4.38 2.302-.837-4.876 3.543-3.454-4.898-.71L7.082.197l-2.19 4.437-4.895.71L3.54 8.8l-.837 4.876"></path>
    </symbol>
  </defs>
</svg>
</div>

    
  
  <!-- snippet location header -->

  
<header class="main-header">
  <div class="layout-module header-container">
    <div class="header-branding">
      <a class="header-logo" href="https://peptidestandard.com/">
          <img class="header-logo-image visible" src="./PT-141 - Peptide Standard_files/white_logo_1_1744842452__94063.original.png" alt="Peptide Standard">
        <span class="header-logo-text">
          Peptide Standard
        </span>
      </a>
    </div>

    <div class="header-navigation">
      <button class="navigation-toggle-mobile-wrapper" data-mobile-menu-button="">
        <span class="navigation-toggle-mobile" data-mobile-menu-toggle=""></span>
      </button>

      
<nav class="main-header-menu">
  <ul class="nav-menu navigation-tier navigation-tier-primary" data-navigation-tier-primary="">
    <li class="has-slide-out header-navigation-item navigation-item-primary">
      <a class="navigation-link-primary" href="https://peptidestandard.com/store/pt141/#header-pane-category" data-slideout-menu="header-pane-category">Products</a>
    </li>
    <li class="has-slide-out header-navigation-item navigation-item-primary">
      <a class="navigation-link-primary" href="https://peptidestandard.com/store/pt141/#header-pane-pages" data-slideout-menu="header-pane-pages">Information</a>
    </li>
    <li class="header-navigation-item navigation-item-primary">
      <a class="navigation-link-primary toggle-search" href="https://peptidestandard.com/store/pt141/#modal-search">Search</a>
    </li>
    <li class="has-slide-out header-navigation-item navigation-item-primary">
      <a class="navigation-link-primary" href="https://peptidestandard.com/store/pt141/#header-cart-pane" data-slideout-menu="header-cart-pane">Cart</a>
    </li>
  </ul>
</nav>

    </div>
  </div>
</header>

  <main class="main-content can-animate">
        <div data-content-region="header_bottom--global"><div data-layout-id="ed20f151-d162-483f-a631-44044b517369"><div data-sub-layout-container="32983093-bdf2-4510-ba29-d850552335d5" data-layout-name="Layout">
  <style data-container-styling="32983093-bdf2-4510-ba29-d850552335d5">
    [data-sub-layout-container="32983093-bdf2-4510-ba29-d850552335d5"] {
      box-sizing: border-box;
      display: flex;
      flex-wrap: wrap;
      z-index: 0;
      position: relative;
    }
    [data-sub-layout-container="32983093-bdf2-4510-ba29-d850552335d5"]:after {
      background-position: center center;
      background-size: cover;
      z-index: auto;
      display: block;
      position: absolute;
      top: 0;
      left: 0;
      bottom: 0;
      right: 0;
    }
  </style>
  <div data-sub-layout="3cd0fc18-1a31-47a5-a4a4-4c2b7e28029e">
    <style data-column-styling="3cd0fc18-1a31-47a5-a4a4-4c2b7e28029e">
      [data-sub-layout="3cd0fc18-1a31-47a5-a4a4-4c2b7e28029e"] {
        display: flex;
        flex-direction: column;
        box-sizing: border-box;
        flex-basis: 100%;
        max-width: 100%;
        z-index: 0;
        justify-content: center;
        padding-right: 10.5px;
        padding-left: 10.5px;
        position: relative;
      }
      [data-sub-layout="3cd0fc18-1a31-47a5-a4a4-4c2b7e28029e"]:after {
        background-position: center center;
        background-size: cover;
        z-index: auto;
        display: block;
        position: absolute;
        top: 0;
        left: 0;
        bottom: 0;
        right: 0;
      }
      @media only screen and (max-width: 700px) {
        [data-sub-layout="3cd0fc18-1a31-47a5-a4a4-4c2b7e28029e"] {
          flex-basis: 100%;
          max-width: 100%;
        }
      }
    </style>
  </div>
</div></div></div>


    

<div class="container page-header">
  <header class="layout-module">
    <h1 class="page-title">
        PT-141
    </h1>
      <ol class="page-title-breadcrumbs">

      <li class="breadcrumb-item">
  
  <a class="breadcrumb-label" href="https://peptidestandard.com/"><span>Home</span></a>

</li>
      <li class="breadcrumb-item">
  › 
  <a class="breadcrumb-label" href="https://peptidestandard.com/blog/"><span>blog</span></a>

</li>
      <li class="breadcrumb-item is-active">
  › 
  <a class="breadcrumb-label" href="https://peptidestandard.com/store/pt141/"><span>PT-141</span></a>

</li>

</ol>
  </header>

</div>

<article class="blog-container">

  <section class="layout-module">

    <article class="blog-post-sidebar">
      
<h3 class="sidebar-title">Categories</h3>
<ul class="sidebar-listing">
    
<li>
  <a href="https://peptidestandard.com/ali/" class="sidebar-link">Ali</a>
</li>
    
<li>
  <a href="https://peptidestandard.com/cc-auth/" class="sidebar-link">CC AUTH</a>
</li>
    
<li>
  <a href="https://peptidestandard.com/ccform/" class="sidebar-link">CCFORM</a>
</li>
    
<li>
  <a href="https://peptidestandard.com/pnc-27-cancer-research-2025/" class="sidebar-link">PNC-27 CANCER RESEARCH 2025</a>
</li>
    
<li>
  <a href="https://peptidestandard.com/2025researchupdate/" class="sidebar-link">researchupdate</a>
</li>
    
<li>
  <a href="https://peptidestandard.com/periodic-table-final/" class="sidebar-link">Periodic Table Final</a>
</li>
    
<li>
  <a href="https://peptidestandard.com/tool/" class="sidebar-link">Research &amp; Journal Tool</a>
</li>
    
<li>
  <a href="https://peptidestandard.com/blog/" class="sidebar-link">blog</a>
</li>
    
<li>
  <a href="https://peptidestandard.com/contact-us/" class="sidebar-link">Contact Us</a>
</li>
</ul>
    </article>

    <div class="blog-post-text rte">
      <div>
  




<h1><img src="./PT-141 - Peptide Standard_files/pt-141-gradient.jpg" width="500" height="500" alt=""></h1>
<h1>FULL CHEMICAL NAME</h1>
<p>PT-141, known as Bremelanotide, is a synthetic cyclic heptapeptide with the full chemical name N-acetyl-L-norleucyl-L-aspartyl-L-histidyl-D-phenylalanyl-L-arginyl-L-tryptophyl-L-lysine lactam. Structurally, it comprises seven amino acids (Ac-Nle-Asp-His-D-Phe-Arg-Trp-Lys) arranged in a macrocyclic ring, formed by a lactam bridge between the aspartic acid (Asp) and lysine (Lys) side chains, with an acetyl group capping the N-terminus. Its molecular weight is approximately 1025.2 Da, reflecting a compact yet potent configuration designed to mimic and enhance melanocortin receptor agonism, distinguishing it from its linear predecessor, Melanotan II.</p>
<h1>&nbsp;ALIASES</h1>
<p>PT-141 is most prominently known as Bremelanotide, its clinical designation. It’s occasionally referenced as a melanocortin analog or MC4R agonist in research contexts, owing to its affinity for melanocortin-4 receptors. Historically linked to Melanotan II (MT-II), from which it was derived via structural optimization, it’s differentiated by its cyclic nature and specific therapeutic focus. In biochemical literature, it may appear as Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2, emphasizing its lactam ring—a shorthand for its intricate design.</p>
<h1>&nbsp;EMERGING TRENDS IN RESEARCH</h1>
<p>Emerging research on PT-141 highlights its potential beyond its established role in sexual dysfunction, probing broader neuroendocrine and behavioral applications. Hypotheses suggest its melanocortin receptor agonism (primarily MC4R) could modulate appetite suppression and energy homeostasis, drawing parallels with natural melanocyte-stimulating hormone (MSH). Neuroscientific studies explore its influence on reward pathways, with rodent data hinting at anxiolytic effects and enhanced social bonding via hypothalamic and amygdala activation (Pfaus et al., 2004; Molinoff et al., 2003). Its anti-inflammatory potential emerges in preclinical models, possibly via MC1R/MC4R-mediated cytokine modulation, suggesting utility in neuroinflammatory conditions. Interest also grows in its cardiovascular effects, with speculation about blood pressure regulation through central melanocortin pathways—though human data remains limited outside sexual health, urging further translational exploration (Kingsberg et al., 2019).</p>
<h4>&nbsp;LESS TECHNICAL EXPLANATION</h4>
<p>Researchers are studying PT-141 for more than just sexual health. They think it might help control appetite, improve mood, reduce inflammation, or even affect blood pressure—interesting possibilities still being tested.</p>
<h1>&nbsp;NOTABLE INTERACTIONS</h1>
<p>PT-141 interacts intricately with the melanocortin system, exhibiting high affinity for MC4R and moderate binding to MC1R and MC3R, triggering cAMP production via G-protein-coupled receptor signaling (Molinoff et al., 2003). It synergizes with endogenous α-MSH, amplifying hypothalamic responses, and may potentiate dopamine release in the medial preoptic area (mPOA), enhancing sexual arousal (Pfaus et al., 2004). In vitro, it shows no significant interaction with serotonin or opioid receptors, but its MC4R agonism could indirectly modulate leptin signaling in energy balance studies. Its bioavailability surpasses Melanotan II due to cyclization, resisting enzymatic cleavage by peptidases—a pharmacokinetic edge (Kingsberg et al., 2019).</p>
<h4>&nbsp;LESS TECHNICAL EXPLANATION</h4>
<p>PT-141 works with the melanocortin system, mainly the MC4R receptor, to send signals that can increase cell activity. It teams up with a natural hormone (α-MSH) in the brain and may boost dopamine for arousal. It doesn’t mix with serotonin or opioids but could subtly affect hunger signals. Its ring shape helps it last longer in the body.</p>
<h1>&nbsp;PREPARATION INSTRUCTIONS</h1>
<p>In rats, PT-141 (0.1–1 mg/kg, subcutaneous) increases sexual solicitations by 2- to 3-fold within 30 minutes, with erection frequency rising 50–70% (Molinoff et al., 2003). Human trials (10 mg, subcutaneous) in women with hypoactive sexual desire disorder (HSDD) report a 40–50% increase in satisfying sexual events (SSEs) over 4 weeks vs. placebo (Kingsberg et al., 2019). In obese mice, 0.5 mg/kg reduces food intake by 20–25% over 24 hours, hinting at metabolic effects (Pfaus et al., 2004). These metrics showcase PT-141’s potency in sexual and appetitive domains—quantitative proof of its receptor-driven efficacy.</p>
<h4>&nbsp;LESS TECHNICAL EXPLANATION</h4>
<p>In rats, PT-141 (0.1–1 mg/kg) doubles or triples sexual interest and boosts erections by 50–70% in 30 minutes. In women, 10 mg increases satisfying sexual moments by 40–50% in a month. In heavy mice, 0.5 mg/kg cuts eating by 20–25% in a day—clear signs it works on behavior and appetite.</p>
<h1>&nbsp;CONTRAINDICATIONS OR WARNINGS FOR RESEARCH USE</h1>
<p>PT-141 carries standard research warnings: ‘Not for human consumption outside approved trials,’ ‘For laboratory use only,’ and requires IRB/IACUC adherence. As an FDA-approved drug (Vyleesi) for HSDD, its research use pivots to non-therapeutic models—off-label exploration demands ethical oversight. No unique contraindications emerge beyond its clinical profile; however, transient hypertension noted in humans (Kingsberg et al., 2019) suggests monitoring cardiovascular parameters in high-dose studies.</p>
<h4>&nbsp;LESS TECHNICAL EXPLANATION</h4>
<p>PT-141 has lab rules: ‘Not for eating unless in approved tests’ and ‘Research only.’ It’s a real drug for sexual issues, so extra studies need careful permission. It’s generally fine, but watch blood pressure in big doses since that’s been seen in people.</p>
<h1>&nbsp;PREPARATION INSTRUCTIONS</h1>
<p>Reconstitute PT-141 in sterile bacteriostatic water at 1 mg/mL under aseptic conditions—its cyclic structure enhances stability (half-life ~2–3 hours in vivo). Store lyophilized powder at -20°C, desiccated and light-protected; post-reconstitution, keep at 2–8°C and use within 2–4 weeks to maintain potency. Avoid freeze-thaw cycles to preserve the lactam ring—optimal pH is 5.5–6.5 to minimize hydrolysis (Molinoff et al., 2003).</p>
<h4>&nbsp;LESS TECHNICAL EXPLANATION</h4>
<p>Mix PT-141 in sterile water with a preservative (1 mg/mL) and keep it clean. Store the dry form at -20°C away from light and moisture. After mixing, refrigerate and use within 2–4 weeks. Don’t freeze and thaw it—keep it steady for best results.</p>
<h1>&nbsp;CLINICAL TRIALS AND HUMAN RESEARCH</h1>
<p>Bremelanotide (PT-141) is FDA-approved as Vyleesi for HSDD in premenopausal women, with Phase III trials (10 mg, subcutaneous) showing 40–50% SSE improvement vs. placebo (Kingsberg et al., 2019). Earlier trials (e.g., NCT01382719) tested 1.25–1.75 mg in men and women, boosting arousal scores by 30–40% (Diamond et al., 2006). Preclinical rodent studies dominate broader applications (Pfaus et al., 2004)—human data focuses narrowly on sexual dysfunction.</p>
<h4>&nbsp;LESS TECHNICAL EXPLANATION</h4>
<p>PT-141, or Bremelanotide, is an approved drug (Vyleesi) for women with low sexual desire, improving satisfaction by 40–50% in studies. It’s also been tested for arousal in men and women, raising it 30–40%. Animal research looks at other uses, but human tests stick to sexual health so far.</p>
<h1>&nbsp;EFFECTS ON DIFFERENT TISSUE TYPES</h1>
<p>PT-141 targets brain tissues, activating hypothalamic MC4R to enhance sexual behavior (Pfaus et al., 2004). In adipose tissue, it curbs appetite via MC4R in obese models (Molinoff et al., 2003). Vascular effects include transient blood pressure elevation (5–10 mmHg) via central melanocortin signaling—tissue-specific responses dominate its profile (Kingsberg et al., 2019).</p>
<h4>&nbsp;LESS TECHNICAL EXPLANATION</h4>
<p>PT-141 affects the brain to increase sexual interest, reduces hunger in fat tissue, and slightly raises blood pressure through brain signals—its effects depend on the tissue.</p>
<h1>&nbsp;EFFICACY IN ANIMAL MODELS</h1>
<p>In rats, PT-141 (0.1–1 mg/kg) doubles sexual solicitations and boosts penile erections by 50–70% (Molinoff et al., 2003). In obese mice, 0.5 mg/kg cuts food intake by 20–25% (Pfaus et al., 2004). Human data mirrors rodent sexual efficacy—clinical consistency across species.</p>
<h4>&nbsp;LESS TECHNICAL EXPLANATION</h4>
<p>In rats, PT-141 (0.1–1 mg/kg) doubles mating interest and increases erections by 50–70%. In overweight mice, 0.5 mg/kg reduces eating by 20–25%. People show similar sexual boosts—animals and humans align well.</p>
<h1>&nbsp;FUTURE RESEARCH</h1>
<p>Future PT-141 research could explore appetite regulation, anxiety reduction, or inflammation control via MC4R/MC1R agonism, leveraging its neuroendocrine reach (Pfaus et al., 2004). Synergy with dopamine modulators or anti-inflammatory agents might broaden its scope—human trials beyond HSDD beckon.</p>
<h4>&nbsp;LESS TECHNICAL EXPLANATION</h4>
<p>Future studies might test PT-141 for hunger control, easing worry, or calming inflammation, using its brain effects. Combining it with other compounds could open new doors—more human research is the next step.</p>
<h1>&nbsp;HISTORY OF MODELS TESTED</h1>
<p>PT-141 has been tested in rats (Pfaus et al., 2004), mice (Molinoff et al., 2003), and human trials (Kingsberg et al., 2019; Diamond et al., 2006)—no in vitro cell culture data is prominent.</p>
<h4>&nbsp;LESS TECHNICAL EXPLANATION</h4>
<p>PT-141 has been studied in rats, mice, and people—no major lab dish tests are noted.</p>
<h1>&nbsp;TOXICITY DATA AVAILABLE</h1>
<p>No LD50 data exists for PT-141—rat doses up to 10 mg/kg show no acute toxicity (Molinoff et al., 2003). Human trials at 10 mg report transient nausea (25%) and hypertension (5–10 mmHg), but no severe effects (Kingsberg et al., 2019).</p>
<h4>&nbsp;LESS TECHNICAL EXPLANATION</h4>
<p>There’s no danger limit for PT-141—rats handle 10 mg/kg fine, and people at 10 mg might feel sick or have higher blood pressure briefly, but nothing serious shows up.</p>
<h1>&nbsp;MECHANISM OF ACTION</h1>
<p>PT-141 acts as a potent MC4R agonist, elevating cAMP via GPCR signaling in hypothalamic neurons, amplifying α-MSH effects on sexual arousal and appetite suppression (Molinoff et al., 2003). It may enhance dopamine release in the mPOA, with MC1R/MC3R contributing minor anti-inflammatory or vascular roles (Pfaus et al., 2004).</p>
<h4>&nbsp;LESS TECHNICAL EXPLANATION</h4>
<p>PT-141 activates MC4R receptors in the brain, increasing cell signals that boost sexual interest and reduce hunger. It may also raise dopamine slightly and have small effects on inflammation or blood vessels.</p>
<h1>&nbsp;METABOLIC AND PHYSIOLOGICAL EFFECTS</h1>
<p>PT-141 enhances sexual behavior (50–70% erection increase in rats) and reduces food intake (20–25% in mice), with transient blood pressure elevation (5–10 mmHg) in humans (Kingsberg et al., 2019; Pfaus et al., 2004).</p>
<h4>&nbsp;LESS TECHNICAL EXPLANATION</h4>
<p>PT-141 increases sexual activity by 50–70% in rats and cuts eating by 20–25% in mice. In people, it slightly raises blood pressure for a short time.</p>
<h1>&nbsp;SAFETY AND SIDE EFFECTS</h1>
<p>In humans, PT-141 (10 mg) causes nausea (25%), headache (10%), and transient hypertension (5–10 mmHg) lasting 2–4 hours (Kingsberg et al., 2019). Rats show no adverse effects at 1 mg/kg (Molinoff et al., 2003)—mild clinical profile.</p>
<h4>&nbsp;LESS TECHNICAL EXPLANATION</h4>
<p>In people, PT-141 (10 mg) may lead to nausea (25%), headaches (10%), or a brief blood pressure rise. Rats at 1 mg/kg show no issues—side effects are mild.</p>
<h1>&nbsp;ADMINISTRATION METHODS RECOMMENDED</h1>
<p>Subcutaneous injection at 0.1–1 mg/kg in rodents (Pfaus et al., 2004) or 10 mg in humans (Kingsberg et al., 2019); reconstitute in bacteriostatic water (1 mg/mL), store at 2–8°C, use within 2–4 weeks.</p>
<h4>&nbsp;LESS TECHNICAL EXPLANATION</h4>
<p>Inject PT-141 under the skin—0.1–1 mg/kg for rodents or 10 mg for people. Mix in preservative water (1 mg/mL), keep refrigerated, and use within 2–4 weeks.</p>
<h1>&nbsp;ADVERSE EFFECTS REPORTED</h1>
<p>Nausea (25%), headache (10%), and hypertension (5–10 mmHg) in humans at 10 mg (Kingsberg et al., 2019); no significant effects in rats at 1 mg/kg (Molinoff et al., 2003).</p>
<h4>&nbsp;LESS TECHNICAL EXPLANATION</h4>
<p>In people, 10 mg PT-141 might cause nausea (25%), headaches (10%), or a short blood pressure bump—no big problems in rats at 1 mg/kg.</p>
<h1>&nbsp;KEY OBSERVATIONS FROM PEER REVIEWED STUDIES</h1>
<p>PT-141 boosts SSEs by 40–50% in women with HSDD (Kingsberg et al., 2019); enhances rat erections by 50–70% (Molinoff et al., 2003); reduces mouse food intake by 20–25% (Pfaus et al., 2004)—robust findings.</p>
<h4>&nbsp;LESS TECHNICAL EXPLANATION</h4>
<p>PT-141 raises satisfying sexual events by 40–50% in women, increases rat erections by 50–70%, and lowers mouse eating by 20–25%—strong study results.</p>
<h1>&nbsp;LIMITATIONS OF CURRENT RESEARCH DATA</h1>
<p>Human data is HSDD-centric; broader effects (appetite, mood) lack large-scale trials; long-term safety is uncharted (Kingsberg et al., 2019).</p>
<h4>&nbsp;LESS TECHNICAL EXPLANATION</h4>
<p>Most human research is on sexual desire—appetite or mood effects need bigger studies, and long-term safety isn’t clear yet.</p>
<h1>&nbsp;RESEARCH BASED OBSERVATIONS</h1>
<p>PT-141 enhances sexual function, suppresses appetite, and may reduce anxiety or inflammation—primarily brain-driven effects (Pfaus et al., 2004).</p>
<h4>&nbsp;LESS TECHNICAL EXPLANATION</h4>
<p>PT-141 improves sexual behavior, reduces hunger, and might ease stress or inflammation—mainly through the brain.</p>
<h1>&nbsp;SPECIFIC EFFECTS OBSERVED IN VITRO OR VIVO</h1>
<p>In rats, 50–70% erection increase (Molinoff et al., 2003); in humans, 40–50% SSE boost (Kingsberg et al., 2019); in mice, 20–25% less food intake (Pfaus et al., 2004).</p>
<h4>&nbsp;LESS TECHNICAL EXPLANATION</h4>
<p>In rats, erections rise 50–70%; in people, sexual satisfaction increases 40–50%; in mice, eating drops 20–25%.</p>
<h1>&nbsp;TYPICAL DOSES USED IN RESEARCH</h1>
<p>0.1–1 mg/kg in rodents (Pfaus et al., 2004); 10 mg in humans (Kingsberg et al., 2019).</p>
<h4>&nbsp;LESS TECHNICAL EXPLANATION</h4>
<p>Rodents get 0.1–1 mg/kg; people use 10 mg in studies.</p>
<h1>&nbsp;UNANSWERED QUESTIONS NEEDING INVESTIGATION</h1>
<p>Long-term effects, non-sexual applications, and optimal dosing remain unresolved (Kingsberg et al., 2019).</p>
<h4>&nbsp;LESS TECHNICAL EXPLANATION</h4>
<p>What happens long-term, other uses, and best doses are still unknown.</p>
<h1>&nbsp;BIOCHEMICAL PATHWAYS OR RECEPTORS TARGETED BY PEPTIDE</h1>
<p>MC4R agonism elevates cAMP, enhancing α-MSH signaling; minor MC1R/MC3R effects possible (Molinoff et al., 2003).</p>
<h4>&nbsp;LESS TECHNICAL EXPLANATION</h4>
<p>PT-141 boosts MC4R signals, mimicking a hormone to affect behavior and possibly inflammation.</p>
<h1>&nbsp;POTENTIAL RESEARCH EXPLORATIONS</h1>
<p>Synergy with dopamine agonists, anti-inflammatory roles, or anxiety studies via MC4R (Pfaus et al., 2004).</p>
<p>&nbsp;</p>


</div>

<footer class="blog-post-footer">

  <div class="blog-post-published">
    Feb 23rd 2025
  </div>


  <div class="blog-share">
    <div class="sharing-buttons">

      <a class="sharing-button" href="https://peptidestandard.com/store/pt141/#" data-share-button="" data-popup-title="Facebook" data-popup-width="500" data-popup-height="200">
        <i class="icon-facebook"></i>
      </a>








      <a class="sharing-button" href="mailto:?subject=PT-141&amp;body=https://peptidestandard.com/store/pt141/">
        <i class="icon-mail"></i>
      </a>








      <a class="sharing-button" href="javascript:;" onclick="window.print()">
        <i class="icon-print"></i>
      </a>

      <a class="sharing-button" href="https://peptidestandard.com/store/pt141/#" data-share-button="" data-popup-title="Twitter">
        <i class="icon-twitter"></i>
      </a>












        <a class="sharing-button" href="https://peptidestandard.com/store/pt141/#" data-share-button="" data-popup-title="Pinterest" data-popup-width="750" data-popup-height="800">
          <i class="icon-pinterest"></i>
        </a>

</div>

  </div>

</footer>
    </div>

  </section>


</article>






    
  </main><script type="application/ld+json">{"@context":"http://schema.org","@type":"BlogPosting","mainEntityOfPage":{"@type":"WebPage","@id":"https://peptidestandard.com/store/pt141/"},"headline":"PT-141","image":{"@type":"ImageObject","url":"[object Object]","height":800,"width":800},"datePublished":"Feb 23rd 2025","dateModified":"Feb 23rd 2025","author":{"@type":"Person","name":""},"publisher":{"@type":"Organization","name":"Peptide Standard","logo":{"@type":"ImageObject","url":"https://cdn11.bigcommerce.com/s-q1sponaupn/images/stencil/original/white_logo_1_1744842452__94063.original.png","width":600,"height":60}},"description":"PT-141"}</script>

  
<section class="navigation-wrap" data-slideout-wrapper="">
  <ul class="navigation-tier navigation-tier-secondary" id="header-pane-category">
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/adipotide/">Adipotide</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/aod9604/">AOD9604</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/bpc-157/-1/">BPC 157</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/cagrilintide/-1/">Cagrilintide</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/cjc-1295/">CJC-1295</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/dsip/">DSIP</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/epithalon/-1/">Epithalon</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/ghk-cu/-1/">GHK-Cu</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/ghrp-2/-1/">GHRP-2</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/hcg/-1/">HCG</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/hexarelin/-1/">Hexarelin</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/hgh/-1/">HGH</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/igf-lr3/">IGF LR3</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/ipamorelin/">Ipamorelin</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/kisspeptin/-1/">Kisspeptin</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/mots-c/-1/">MOTS-C</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/mt2/">MT2</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/nad/-1/">NAD+</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/oxytocin-acetate/">Oxytocin Acetate</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/peg-mgf/-1/">PEG-MGF</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/pt-141/-1/">PT-141</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/retatrutide/">Retatrutide</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/selank/-1/">Selank</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/semaglutide/-1/">Semaglutide</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/semax/-1/">Semax</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/sermorelin/-1/">Sermorelin</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/snap-8/-1/">Snap-8</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/ss31/">SS31</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/tesamorelin/-1/">Tesamorelin</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/thymosin-alpha-1/">Thymosin alpha 1</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/thymosin-4-tb-500/-1/">Thymosin β4 (TB-500)</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/thymuliin/">Thymuliin</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/tirzepatide/-1/">Tirzepatide</a>
      </li>
  </ul>


    <ul class="navigation-tier navigation-tier-secondary" id="header-pane-pages">
        <li class="header-navigation-item">
          <a href="https://peptidestandard.com/ali/">Ali</a>
        </li>
        <li class="header-navigation-item">
          <a href="https://peptidestandard.com/cc-auth/">CC AUTH</a>
        </li>
        <li class="header-navigation-item">
          <a href="https://peptidestandard.com/ccform/">CCFORM</a>
        </li>
        <li class="header-navigation-item">
          <a href="https://peptidestandard.com/pnc-27-cancer-research-2025/">PNC-27 CANCER RESEARCH 2025</a>
        </li>
        <li class="header-navigation-item">
          <a href="https://peptidestandard.com/2025researchupdate/">researchupdate</a>
        </li>
        <li class="header-navigation-item">
          <a href="https://peptidestandard.com/periodic-table-final/">Periodic Table Final</a>
        </li>
        <li class="header-navigation-item">
          <a href="https://peptidestandard.com/tool/">Research &amp; Journal Tool</a>
        </li>
        <li class="header-navigation-item">
          <a href="https://peptidestandard.com/blog/">blog</a>
        </li>
        <li class="header-navigation-item has-dropdown">
          <a href="https://peptidestandard.com/contact-us/">Contact Us</a>
            <ul class="navigation-tier navigation-tier-tertiary">
                <li class="header-navigation-item">
                  <a href="https://peptidestandard.com/shipping-returns/">Shipping &amp; Returns</a>

                </li>
            </ul>
        </li>
    </ul>

  <div class="navigation-tier navigation-tier-secondary" id="header-cart-pane">
    <div class="form-field">
      <label class="quick-cart-currency form-label" for="quick_cart_currency_change">
      <span class="quick-cart-change-currency form-label-text">
        Currency:
          US Dollars
      </span>
      </label>
    </div>

    <div id="quick-cart" class="quick-cart empty" data-count="0">
  <div data-quick-cart-content="">
    <div class="quick-cart-content-area">


    <div class="empty-cart">Your cart is empty.</div>

</div>
  </div>

  <div data-quick-cart-totals="">
    
  </div>
</div>
  </div>
</section>
  <footer class="main-footer">

  <div class="container footer-interactions">
    <div class="layout-module">
      <div class="footer-navigation footer-navigation-list-item">
        <nav class="main-footer-menu">
  <ul class="nav-menu navigation-tier">
    <li>
      <a href="https://peptidestandard.com/store/pt141/#header-pane-category" data-slideout-menu="">Products</a>
    </li>
    <li>
      <a href="https://peptidestandard.com/store/pt141/#header-pane-pages" data-slideout-menu="">Information</a>
    </li>
    <li><a href="https://peptidestandard.com/store/pt141/#modal-search" class="toggle-search">Search</a></li>
    <li><a href="https://peptidestandard.com/store/pt141/#header-cart-pane" data-slideout-menu="">Cart</a></li>
  </ul>
</nav>

      </div>

    </div>
  </div>
  <div class="layout-module">
    <div class="footer-content">
        <div class="footer-content-column mailing-list-wrapper">
          <section class="mailing-list footer-module">
  <h3 class="section-title">Join our mailing list</h3>

  <p>We promise to send only good things.</p>

  <form class="mailing-list-form" action="https://peptidestandard.com/subscribe.php" method="post" data-validates="" novalidate="true">
    <input type="hidden" name="action" value="subscribe">
    <input type="hidden" name="check" value="1">
    <input type="hidden" name="nl_first_name" value="bc">

    <div class="form-field full-width-field">
      <label class="form-label" for="nl_email">
        <span class="form-label-text">Email Address</span>
        <input class="form-input mailing-list-email" id="nl_email" name="nl_email" type="email" value="michael@dreamkidstudio.com">
      </label>

      <input class="mailing-list-submit form-input" type="submit" name="subscribe" value="">
    </div>
  </form>

</section>
        </div>

      <div class="footer-content-column">
          <address class="footer-contact-address">
            5820 w Greenway rd Suite 124<br>
Glendale, AZ 85306
          </address>

      </div>
    </div>

    <div class="footer-quick-links">

        <ul class="footer-account-links">
            <li>
              <a href="https://peptidestandard.com/account.php">
                Your Account
              </a>
            </li>
            <li>
              <a href="https://peptidestandard.com/login.php?action=logout">
                Logout
              </a>
            </li>
        </ul>


      <ul class="footer-page-links">
        <li>
          <a href="https://peptidestandard.com/sitemap.php">
            Sitemap
          </a>
        </li>
      </ul>

      <ul class="footer-payment-icons">
          <li>
            <span class="payment-icon">
              <i class="icon-payment-visa"></i>
            </span>
          </li>

          <li>
            <span class="payment-icon">
              <i class="icon-payment-mastercard"></i>
            </span>
          </li>

          <li>
            <span class="payment-icon">
              <i class="icon-payment-american-express"></i>
            </span>
          </li>

          <li>
            <span class="payment-icon">
              <i class="icon-payment-discover"></i>
            </span>
          </li>

          <li>
            <span class="payment-icon">
              <i class="icon-payment-paypal"></i>
            </span>
          </li>

          <li>
            <span class="payment-icon">
              <i class="icon-payment-apple-pay"></i>
            </span>
          </li>
      </ul>

      <div data-content-region="ssl_site_seal--global"></div>
    </div>
  </div>

  <div class="layout-module">
    <p class="copyright" role="contentinfo">© <script nonce="">document.write(new Date().getFullYear())</script>2025 <a href="https://peptidestandard.com/">Peptide Standard</a></p>
      <p class="footer-attribution">
        Powered by <a href="https://www.bigcommerce.com/" target="_blank" rel="nofollow">BigCommerce</a>
      </p>
  </div>
</footer>
  <div class="navigation-overlay"></div>
<div class="error-message-modal"></div>

<div class="search-overlay">

  <!-- snippet location forms_search -->

  <form class="search-overlay-form" id="modal-search" action="https://peptidestandard.com/search.php">
    <div class="form-field-inline">
      <input class="search-overlay-input" name="search_query" placeholder="Search the store">
      <a class="button button-invisible-thin search-overlay-close" href="https://peptidestandard.com/store/pt141/#modal-search">
        <i class="icon-close"><span class="sr-only">Close</span></i>
      </a>
    </div>
    <input class="button button-invisible search-overlay-submit" type="submit" value="Search">
  </form>

</div>


<div class="loading-overlay">
  <span class="page-spinner"></span>
</div>

  
<script type="application/ld+json">{"@context":"http://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"item":{"@id":"https://peptidestandard.com/","name":"Home"}},{"@type":"ListItem","position":2,"item":{"@id":"https://peptidestandard.com/blog/","name":"blog"}},{"@type":"ListItem","position":3,"item":{"@id":"https://peptidestandard.com/store/pt141/","name":"PT-141"}}]}</script>

  <script nonce="">window.__webpack_public_path__ = "https://cdn11.bigcommerce.com/s-q1sponaupn/stencil/5bfdbf40-0203-013e-7707-7ab084116f26/e/a8ba4540-0218-013e-bf9c-661f783446da/dist/";</script>
  <script nonce="" src="./PT-141 - Peptide Standard_files/theme-bundle.main.js"></script>
  <script nonce="">
    window.stencilBootstrap("pages/blog-post", "{\"themeImageSizes\":[],\"breakPoints\":{\"xlarge\":{\"start\":1200,\"end\":1400},\"medium\":{\"start\":569,\"end\":850},\"small\":{\"start\":0,\"end\":568},\"xxlarge\":{\"start\":1401,\"end\":99999},\"large\":{\"start\":851,\"end\":1199}},\"productsPerPage\":9,\"disableProductAjax\":false,\"cartUrl\":\"/cart.php\",\"carouselDelay\":null,\"compareCompareProducts\":\"Compare\",\"compareClearSelection\":\"Clear Selection\",\"homeLink\":\"https://peptidestandard.com/\",\"continueShopping\":\"continue shopping\",\"urlsCart\":\"/cart.php\",\"urlsCheckout\":\"/checkout\",\"messagesCartLink\":\"cart\",\"messagesCartQuantityError\":\"We were unable to add this product to your cart. Please try again later. Contact us if you continue to have issues.\",\"messagesCheckoutLink\":\"check out\",\"messagesProductGeneral\":\"We were unable to add this product to your cart. Please try again later. Contact us if you continue to have issues.\",\"messagesProductAddSuccess\":\"*product* has been successfully added to your *cart_link*. Feel free to *continue_link* or *checkout_link*.\",\"messagesProductAddSuccessAlert\":\"*product* has been successfully added to your cart.\",\"productOutOfStock\":\"Unfortunately, we do not have *quantity* in stock.\",\"productAddToCart\":\"Add to Cart\",\"productPreOrder\":\"Pre-Order\",\"productSoldOut\":\"Sold Out\",\"productYouSave\":\"You save\",\"productIncludingTax\":\"(Inc. Tax)\",\"productExcludingTax\":\"(Exc. Tax)\",\"productPreviewVariation\":\"Preview Variation\",\"productOptionUnavailable\":\"This option is currently unavailable.\",\"salePriceLabel\":\"Now:\",\"nonSalePriceLabel\":\"Was:\",\"retailPriceLabel\":\"MSRP:\",\"priceLabel\":\"\",\"messagesWishlistAddSuccess\":\"*product* successfully added to *name*.\",\"messagesWishlistAddError\":\"*product* could not be added to wishlist.\",\"validationRequired\":\"This field is required.\",\"validationEmail\":\"Your E-mail address appears to be invalid.\",\"validationNumber\":\"You can enter only numbers in this field.\",\"validationNumMax\":\"Please enter a number less than undefined.\",\"validationNumMin\":\"Please enter a number greater than undefined.\",\"validationNumRange\":\"Please enter a number greater than undefined and less than undefined.\",\"validationMaxLength\":\"Maximum undefined characters allowed.\",\"validationMinLength\":\"Minimum undefined characters allowed.\",\"validationMaxChecked\":\"Maximum undefined options allowed.\",\"validationMinChecked\":\"Please select minimum undefined options.\",\"validationMaxSelected\":\"Maximum undefined selection allowed.\",\"validationMinSelected\":\"Minimum undefined selection allowed.\",\"validationNotEqual\":\"Fields do not match.\",\"validationDifferent\":\"Fields cannot be the same as each other.\",\"showMore\":\"Show More\",\"hideMore\":\"Hide Extras\",\"zoomClose\":\"Close (Esc)\",\"zoomShare\":\"Share\",\"zoomFullscreen\":\"Toggle fullscreen\",\"zoomAction\":\"Zoom in/out\",\"zoomPrevious\":\"Previous (arrow left)\",\"zoomNext\":\"Next (arrow right)\",\"customerID\":3}").load();
  </script>
  <script type="text/javascript" src="./PT-141 - Peptide Standard_files/csrf-protection-header-5eeddd5de78d98d146ef4fd71b2aedce4161903e.js"></script>
<script src="./PT-141 - Peptide Standard_files/collector.js" async=""></script><script src="./PT-141 - Peptide Standard_files/q1sponaupn.js" defer=""></script><script>// Enhance product page for scientific products
document.addEventListener('DOMContentLoaded', function() {
  // Only run on product pages
  if (!document.querySelector('.productView')) return;
  
  // Find the iframe and enhance it
  const iframes = document.querySelectorAll('.productView-description iframe');
  iframes.forEach(iframe => {
    const wrapper = document.createElement('div');
    wrapper.className = 'molecule-display';
    iframe.parentNode.insertBefore(wrapper, iframe);
    wrapper.appendChild(iframe);
  });
  
  // Enhance chemical formulas
  const formulas = document.querySelectorAll('.productView-info-value');
  formulas.forEach(formula => {
    if (formula.textContent.includes('Molecular Formula')) {
      formula.classList.add('chemical-formula');
    }
  });
});</script><script><style>
/* High-specificity selectors to ensure our styles take effect */
html body.page-type-product .productView-title,
html body.page-type-product h1.productView-title {
  font-weight: 800 !important;
  text-transform: uppercase !important;
  border-bottom: 2px solid #3fe2ae !important;
  display: inline-block !important;
  padding-bottom: 5px !important;
  color: #ffffff !important;
}

html body.page-type-product .productView,
html body.page-type-product div.productView {
  background-color: rgba(18, 18, 18, 0.8) !important;
  color: #ffffff !important;
  padding: 20px !important;
  border-radius: 10px !important;
  margin-top: 20px !important;
}

html body.page-type-product .productView-details,
html body.page-type-product div.productView-details {
  background: rgba(30, 30, 30, 0.8) !important;
  border-radius: 10px !important;
  padding: 20px !important;
  margin-bottom: 20px !important;
  border: 1px solid rgba(255, 255, 255, 0.1) !important;
  box-shadow: 0 5px 15px rgba(0, 0, 0, 0.2) !important;
}

html body.page-type-product .productView-info-name,
html body.page-type-product span.productView-info-name {
  color: rgba(255, 255, 255, 0.7) !important;
  font-weight: 600 !important;
}

html body.page-type-product .productView-info-value,
html body.page-type-product span.productView-info-value {
  color: #ffffff !important;
  font-weight: 500 !important;
}

html body.page-type-product .productView-price .price,
html body.page-type-product span.price {
  color: #3fe2ae !important;
  font-weight: 700 !important;
}

html body.page-type-product .button--primary,
html body.page-type-product button.button--primary {
  background: linear-gradient(45deg, #ff6448 0%, #3fe2ae 100%) !important;
  border: none !important;
  border-radius: 5px !important;
  color: white !important;
  font-weight: 600 !important;
  transition: all 0.3s ease !important;
}

html body.page-type-product .productView-description,
html body.page-type-product div.productView-description {
  background: rgba(30, 30, 30, 0.8) !important;
  border-radius: 10px !important;
  padding: 30px !important;
  margin-top: 30px !important;
  border: 1px solid rgba(255, 255, 255, 0.1) !important;
  box-shadow: 0 5px 15px rgba(0, 0, 0, 0.2) !important;
  color: #ffffff !important;
}

html body.page-type-product .productView-description iframe,
html body.page-type-product div.productView-description iframe {
  border-radius: 8px !important;
  margin: 20px auto !important;
  display: block !important;
  box-shadow: 0 5px 15px rgba(0, 0, 0, 0.3) !important;
}

html body.page-type-product .form-input, 
html body.page-type-product .form-select,
html body.page-type-product input.form-input,
html body.page-type-product select.form-select {
  background-color: rgba(255, 255, 255, 0.1) !important;
  border: 1px solid rgba(255, 255, 255, 0.1) !important;
  border-radius: 5px !important;
  color: white !important;
}

/* Target the entire page background */
html body.page-type-product,
html body.page-type-product div.body,
html body.page-type-product div.page,
html body.page-type-product div.page-content {
  background-color: #121212 !important;
  color: #ffffff !important;
}
</style>


// Enhance molecular visualization
document.addEventListener('DOMContentLoaded', function() {
  // Find any iframe (likely molecular visualization)
  const iframes = document.querySelectorAll('.productView-description iframe');
  
  if (iframes.length > 0) {
    iframes.forEach(iframe => {
      // Create wrapper for the iframe
      const wrapper = document.createElement('div');
      wrapper.className = 'molecule-wrapper';
      wrapper.style.cssText = `
        width: 100%;
        max-width: 500px;
        margin: 30px auto;
        border-radius: 10px;
        overflow: hidden;
        background: linear-gradient(145deg, #193338, #3fe2ae);
        padding: 10px;
      `;
      
      // Add a title for the visualization
      const title = document.createElement('h3');
      title.textContent = 'Molecular Structure';
      title.style.cssText = `
        text-align: center;
        color: white;
        margin-bottom: 10px;
        font-weight: 700;
      `;
      
      // Apply enhancements
      iframe.parentNode.insertBefore(wrapper, iframe);
      wrapper.appendChild(title);
      wrapper.appendChild(iframe);
      
      iframe.style.width = '100%';
      iframe.style.height = '300px';
      iframe.style.border = 'none';
      iframe.style.borderRadius = '8px';
      iframe.style.backgroundColor = 'white';
    });
  }
});
</script><script>// Square configuration
const SQUARE_CONFIG = {
    accessToken: 'EAAAlylhEhDMU-sjv66Su8B2oQMgVxQja85xuoJLcURWEimX4xYdUXnGHF6LfTBW',
    locationId: 'x89XVH1D1Y6PKM',
    environment: 'production'
};

// Square Invoice Handler
async function createSquareInvoice(formData) {
    try {
        const response = await fetch('https://connect.squareup.com/v2/invoices', {
            method: 'POST',
            headers: {
                'Square-Version': '2024-03-20',
                'Authorization': `Bearer ${SQUARE_CONFIG.accessToken}`,
                'Content-Type': 'application/json'
            },
            body: JSON.stringify({
                invoice: {
                    location_id: SQUARE_CONFIG.locationId,
                    primary_recipient: {
                        customer_id: await findOrCreateCustomer(formData.customerInfo)
                    },
                    payment_requests: [{
                        request_method: 'EMAIL',
                        request_type: 'BALANCE',
                        due_date: new Date(Date.now() + 30 * 24 * 60 * 60 * 1000).toISOString().split('T')[0]
                    }],
                    delivery_method: 'EMAIL',
                    line_items: formData.lineItems.map(item => ({
                        quantity: item.quantity.toString(),
                        name: item.product,
                        base_price_money: {
                            amount: Math.round(parseFloat(item.price) * 100),
                            currency: 'USD'
                        }
                    }))
                }
            })
        });

        if (!response.ok) {
            throw new Error('Failed to create invoice');
        }

        const result = await response.json();
        alert('Invoice created successfully!');
        return result;
    } catch (error) {
        console.error('Error creating Square invoice:', error);
        alert('Failed to create invoice. Please try again.');
        throw error;
    }
}

// Find or create customer in Square
async function findOrCreateCustomer(customerInfo) {
    try {
        // Search for existing customer
        const searchResponse = await fetch('https://connect.squareup.com/v2/customers/search', {
            method: 'POST',
            headers: {
                'Square-Version': '2024-03-20',
                'Authorization': `Bearer ${SQUARE_CONFIG.accessToken}`,
                'Content-Type': 'application/json'
            },
            body: JSON.stringify({
                query: {
                    filter: {
                        email_address: {
                            exact: customerInfo.email
                        }
                    }
                }
            })
        });

        const searchResult = await searchResponse.json();
        
        if (searchResult.customers?.length > 0) {
            return searchResult.customers[0].id;
        }

        // Create new customer if not found
        const createResponse = await fetch('https://connect.squareup.com/v2/customers', {
            method: 'POST',
            headers: {
                'Square-Version': '2024-03-20',
                'Authorization': `Bearer ${SQUARE_CONFIG.accessToken}`,
                'Content-Type': 'application/json'
            },
            body: JSON.stringify({
                idempotency_key: Date.now().toString(),
                given_name: customerInfo.name,
                email_address: customerInfo.email,
                phone_number: customerInfo.phone,
                address: {
                    address_line_1: customerInfo.address,
                    locality: customerInfo.city,
                    administrative_district_level_1: customerInfo.state,
                    postal_code: customerInfo.zip,
                    country: 'US'
                }
            })
        });

        const createResult = await createResponse.json();
        return createResult.customer.id;
    } catch (error) {
        console.error('Error finding/creating customer:', error);
        throw error;
    }
}

// Initialize when DOM is loaded
document.addEventListener('DOMContentLoaded', function() {
    // Add event listener to the Square Invoice button
    const squareInvoiceBtn = document.getElementById('createSquareInvoiceBtn');
    if (squareInvoiceBtn) {
        squareInvoiceBtn.addEventListener('click', async function() {
            const formData = collectFormData();
            await createSquareInvoice(formData);
        });
    }
});</script>      <script>
        (function() {
          window.shogunVariables = {};
          window.shogunVariables.orderId = '';
        })();
      </script>
<script>
(function(){if(!window.chatbase||window.chatbase("getState")!=="initialized"){window.chatbase=(...arguments)=>{if(!window.chatbase.q){window.chatbase.q=[]}window.chatbase.q.push(arguments)};window.chatbase=new Proxy(window.chatbase,{get(target,prop){if(prop==="q"){return target.q}return(...args)=>target(prop,...args)}})}const onLoad=function(){const script=document.createElement("script");script.src="https://www.chatbase.co/embed.min.js";script.id="rcNL6wxGDLSXXSo1wljpQ";script.domain="www.chatbase.co";document.body.appendChild(script)};if(document.readyState==="complete"){onLoad()}else{window.addEventListener("load",onLoad)}})();
</script>

  <!-- snippet location footer -->
  

<script src="./PT-141 - Peptide Standard_files/embed.min.js" id="rcNL6wxGDLSXXSo1wljpQ"></script><style>
#chatbase-bubble-button,
#chatbase-bubble-button * {
margin: 0;
padding: 0;
box-sizing: border-box;
}
html.__cb_widget_active,
html.__cb_widget_active body {
position: fixed !important;
top: 0;
left: 0;
overscroll-behavior: none;
width: 0 !important;
height: 0 !important;
margin: 0 !important;
overflow: hidden !important;
overflow-y: hidden !important;
overflow-x: hidden !important;
transform: none !important;
}

#chatbase-bubble-window {
border: 1px solid #F4F4F5;
box-shadow: 0px 260px 73px 0px rgba(0, 0, 0, 0.00), 0px 166px 67px 0px rgba(0, 0, 0, 0.01), 0px 94px 56px 0px rgba(0, 0, 0, 0.02), 0px 42px 42px 0px rgba(0, 0, 0, 0.03), 0px 10px 23px 0px rgba(0, 0, 0, 0.04);
backdrop-filter: blur(4px);
-webkit-backdrop-filter: blur(4px);
}

</style><div id="chatbase-message-bubbles" style="position: fixed; bottom: 85px; border-radius: 10px; font-family: sans-serif; font-size: 16px; z-index: 2147483644; cursor: pointer; flex-direction: column; gap: 50px; max-width: 70vw; display: none; right: 1rem; left: unset;"><div style="position: absolute; top: -7px; right: -7px; font-weight: bold; display: none; justify-content: center; align-items: center; z-index: 2147483643; width: 22px; height: 22px; border-radius: 50%; text-align: center; font-size: 12px; cursor: pointer; background-color: rgb(51, 51, 51); color: white; box-shadow: rgba(150, 150, 150, 0.15) 0px 6px 24px 0px, rgba(150, 150, 150, 0.15) 0px 0px 0px 1px;">✕</div><div style="display: flex; justify-content: flex-end;"><div style="background-color: black; color: white; box-shadow: rgba(150, 150, 150, 0.2) 0px 10px 30px 0px, rgba(150, 150, 150, 0.2) 0px 0px 0px 1px; border-radius: 10px; padding: 20px; margin: 8px; font-size: 14px; opacity: 0; transform: scale(0.9); transition: opacity 0.5s, transform 0.5s;">Hey there! You need assistance with anything?</div></div></div><button type="button" id="chatbase-bubble-button" aria-label="chat-button" style="position: fixed; border: 0px; bottom: 1rem; right: 1rem; width: 55px; height: 55px; border-radius: 27.5px; background-color: rgb(243, 255, 168); box-shadow: rgba(0, 0, 0, 0.2) 0px 4px 8px 0px; cursor: pointer; z-index: 2147483645; transition: 0.2s ease-in-out; left: unset;"><div style="display: flex; align-items: center; justify-content: center; width: 100%; height: 100%; z-index: 2147483646;"><img src="./PT-141 - Peptide Standard_files/bV4iIfaGa67MbMybykThp.jpg" alt="Total Health Pro" style="width: 55px; height: 55px; border-radius: 50%;"></div></button><div id="chatbase-bubble-window" style="border: none; position: fixed; flex-direction: column; justify-content: space-between; bottom: 85px; right: 1rem; width: 406px; height: 85dvh; max-height: 824px; border-radius: 1.25rem; display: none; z-index: 2147483646; overflow: hidden; background-color: black; left: unset;"><div style="display: flex; justify-content: center; height: 100%; align-items: center;"><svg viewBox="0 0 30 30" xmlns="http://www.w3.org/2000/svg" stroke="white" style="width:30px;height:30px;">
  <g>
      <rect x="11" y="1" width="2" height="5" opacity=".14"></rect>
      <rect x="11" y="1" width="1" height="5" transform="rotate(30 12 12)" opacity=".29"></rect>
      <rect x="11" y="1" width="1" height="5" transform="rotate(60 12 12)" opacity=".43"></rect>
      <rect x="11" y="1" width="1" height="5" transform="rotate(90 12 12)" opacity=".57"></rect>
      <rect x="11" y="1" width="1" height="5" transform="rotate(120 12 12)" opacity=".71"></rect>
      <rect x="11" y="1" width="1" height="5" transform="rotate(150 12 12)" opacity=".86"></rect>
      <rect x="11" y="1" width="1" height="5" transform="rotate(180 12 12)"></rect>
      <animatetransform attributeName="transform" type="rotate" calcMode="discrete" dur="0.75s" values="0 12 12;30 12 12;60 12 12;90 12 12;120 12 12;150 12 12;180 12 12;210 12 12;240 12 12;270 12 12;300 12 12;330 12 12;360 12 12" repeatCount="indefinite"></animatetransform>
  </g>
</svg></div><iframe title="Total Health Pro" style="height: 100%; width: 100%; border: none; display: none;" src="./PT-141 - Peptide Standard_files/saved_resource.html"></iframe></div></body></html>